Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of the fiscal period ended Monday, March 31, 2025.
Reported annual fiscal-period values; no daily interpolation.
FREE CASH FLOW YIELD
N/A
FREE CASH FLOW YIELD AVG TTM
-496.25%
FREE CASH FLOW YIELD AVG 3Y
-255.12%
FREE CASH FLOW YIELD AVG 5Y
-171.49%
FREE CASH FLOW YIELD AVG 10Y
N/A
FREE CASH FLOW YIELD AVG 15Y
N/A
FREE CASH FLOW YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
23andMe Holding Co.
Market Cap
$15.31M
Free Cash Flow Yield
N/A
TTM Avg
-496.25%
3Y Avg
-255.12%
5Y Avg
-171.49%
Market Cap
$471.59M
Free Cash Flow Yield
N/A
TTM Avg
-9.13%
3Y Avg
-7.86%
5Y Avg
-7.86%
Market Cap
$1.21B
Free Cash Flow Yield
18.59%
TTM Avg
18.18%
3Y Avg
15.53%
5Y Avg
11.83%
Market Cap
$2.64B
Free Cash Flow Yield
5.46%
TTM Avg
2.77%
3Y Avg
2.76%
5Y Avg
2.76%
Market Cap
$2.68B
Free Cash Flow Yield
3.89%
TTM Avg
4.48%
3Y Avg
5.57%
5Y Avg
5.60%
Market Cap
$6.19B
Free Cash Flow Yield
1.20%
TTM Avg
1.32%
3Y Avg
1.58%
5Y Avg
1.58%
Market Cap
$8.09B
Free Cash Flow Yield
27.17%
TTM Avg
25.14%
3Y Avg
21.20%
5Y Avg
19.51%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 23andMe Holding Co. (ME) | $15.31M | N/A | -496.25% | -255.12% | -171.49% |
| NRC Health (NRC)vs › | $439.69M | 5.04% | 3.53% | 3.83% | 3.67% |
| Shoulder Innovations, Inc. (SI)vs › | $471.59M | N/A | -9.13% | -7.86% | -7.86% |
| Teladoc Health, Inc. (TDOC)vs › | $1.21B | 18.59% | 18.18% | 15.53% | 11.83% |
| TransMedics Group, Inc. (TMDX)vs › | $2.64B | 5.46% | 2.77% | 2.76% | 2.76% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.68B | 3.89% | 4.48% | 5.57% | 5.60% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.19B | 1.20% | 1.32% | 1.58% | 1.58% |
| Tempus AI, Inc. (TEM)vs › | $7.69B | N/A | -3.09% | -3.23% | -3.23% |
| Oscar Health, Inc. (OSCR)vs › | $8.09B | 27.17% | 25.14% | 21.20% | 19.51% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.80B | 4.07% | 4.47% | 3.26% | 2.83% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | FREE CASH FLOW YIELD |
|---|---|
| 2025-03-31 | -924.20% |
| 2024-03-31 | -68.29% |
| 2023-03-31 | -17.16% |
| 2022-03-31 | -10.81% |
| 2021-03-31 | -1.97% |
| 2020-03-31 | -6.51% |
| 2019-03-31 | -3.16% |
